Pancreatic ductal adenocarcinoma and transcription factors: Role of c-Myc

Journal of Gastrointestinal Cancer

Volumn 42, Issue 2, 2011, Pages 76-84

  Skoudy, Anouchka ^a   Hernández Muñoz, Inmaculada ^a   Navarro, Pilar ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

c Myc; Ela myc transgenic mouse; Pancreatic development; Pancreatic ductal adenocarcinoma; Transcription factor

Indexed keywords

PROTEIN P16; PROTEIN P53; SMAD4 PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER MORTALITY; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CULTURAL ANTHROPOLOGY; DNA REPLICATION; EXPERIMENTAL MODEL; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GROWTH REGULATION; HUMAN; METASTASIS; NONHUMAN; ONCOGENE C MYC; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PANCREATIC DUCTAL ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TISSUE DIFFERENTIATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; GENES, MYC; HUMANS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION;

EID: 79956207689     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-011-9258-0     Document Type: Article

References (78)

1. S Jones X Zhang DW Parsons, et al. 2008 Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 1801 1806 18772397 10.1126/science.1164368 1:CAS:528:DC%2BD1cXhtFCrtLrL
2. AH Brivanlou JE Darnell 2002 Signal transduction and the control of gene expression Science 295 813 818 11823631 10.1126/science.1066355 1:CAS:528:DC%2BD38XhtFams70%3D (Pubitemid 34118354)
3. N Meyer LZ Penn 2008 Reflecting on 25 years with MYC Nat Rev Cancer 8 976 990 19029958 10.1038/nrc2231 1:CAS:528:DC%2BD1cXhsVWhu7rJ
4. R Dalla-Favera M Bregni J Erikson D Patterson RC Gallo CM Croce 1982 Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells Proc Natl Acad Sci U S A 79 7824 7827 6961453 10.1073/pnas.79.24.7824 1:CAS:528:DyaL3sXkslyqtQ%3D%3D (Pubitemid 13182471)
5. R Taub I Kirsch C Morton G Lenoir D Swan S Tronick S Aaronson P Leder 1982 Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells Proc Natl Acad Sci U S A 79 7837 7841 6818551 10.1073/pnas.79.24.7837 1:CAS:528:DyaL3sXms1emtg%3D%3D (Pubitemid 13182474)
6. JH Patel AP Loboda MK Showe LC Showe SB McMahon 2004 Analysis of genomic targets reveals complex functions of MYC Nat Rev Cancer 4 562 568 15229481 10.1038/nrc1393 1:CAS:528:DC%2BD2cXlt1Oktrc%3D (Pubitemid 38868625)
7. M Eilers RN Eisenman 2008 Myc's broad reach Genes Dev 22 2755 2766 18923074 10.1101/gad.1712408 1:CAS:528:DC%2BD1cXht12ht7zE
8. D Dominguez-Sola CY Ying C Grandori L Ruggiero B Chen M Li DA Galloway W Gu J Gautier R Dalla-Favera 2007 Non-transcriptional control of DNA replication by c-Myc Nature 448 445 451 17597761 10.1038/nature05953 1:CAS:528: DC%2BD2sXotFajtbc%3D (Pubitemid 47123512)
9. VH Cowling MD Cole 2007 The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding Mol Cell Biol 27 2059 2073 17242204 10.1128/MCB.01828-06 1:CAS:528:DC%2BD2sXjsVSrsrc%3D (Pubitemid 46418464)
10. J Vervoorts J Luscher-Firzlaff B Luscher 2006 The ins and outs of MYC regulation by posttranslational mechanisms J Biol Chem 281 34725 34729 16987807 10.1074/jbc.R600017200 1:CAS:528:DC%2BD28XhtF2gtbrK (Pubitemid 46036511)
11. BW Freie RN Eisenman 2008 Ratcheting Myc Cancer Cell 14 425 426 19061831 10.1016/j.ccr.2008.11.008 1:CAS:528:DC%2BD1cXhsFahsrfN
12. J Liu D Levens 2006 Making myc Curr Top Microbiol Immunol 302 1 32 16620023 10.1007/3-540-32952-8-1 1:CAS:528:DC%2BD28XjsFOmtrw%3D (Pubitemid 43273330)
13. DJ Murphy MR Junttila L Pouyet A Karnezis K Shchors DA Bui L Brown-Swigart L Johnson GI Evan 2008 Distinct thresholds govern Myc's biological output in vivo Cancer Cell 14 447 457 19061836 10.1016/j.ccr.2008.10.018 1:CAS:528:DC%2BD1cXhsFahsrfK
14. G Evan T Littlewood 1998 A matter of life and cell death Science 281 1317 1322 9721090 10.1126/science.281.5381.1317 1:CAS:528:DyaK1cXlvVegsLY%3D (Pubitemid 28406818)
15. SW Lowe E Cepero G Evan 2004 Intrinsic tumour suppression Nature 432 307 315 15549092 10.1038/nature03098 1:CAS:528:DC%2BD2cXpvVCjtLg%3D (Pubitemid 39551658)
16. P Cartwright C McLean A Sheppard D Rivett K Jones S Dalton 2005 LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism Development 132 885 896 15673569 10.1242/dev.01670 1:CAS:528: DC%2BD2MXjtFCht7k%3D (Pubitemid 40484924)
17. PS Knoepfler PF Cheng RN Eisenman 2002 N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation Genes Dev 16 2699 2712 12381668 10.1101/gad.1021202 1:CAS:528:DC%2BD38XotFeksr4%3D
18. I Arnold FM Watt 2001 c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny Curr Biol 11 558 568 11369200 10.1016/S0960-9822(01)00154-3 1:CAS:528: DC%2BD3MXjtlenurc%3D (Pubitemid 32324758)
19. RL Waikel Y Kawachi PA Waikel XJ Wang DR Roop 2001 Deregulated expression of c-Myc depletes epidermal stem cells Nat Genet 28 165 168 11381265 10.1038/88889 1:CAS:528:DC%2BD3MXktFOrtLc%3D (Pubitemid 32538063)
20. A Wilson MJ Murphy T Oskarsson K Kaloulis MD Bettess GM Oser AC Pasche C Knabenhans HR Macdonald A Trumpp 2004 c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation Genes Dev 18 2747 2763 15545632 10.1101/gad.313104 1:CAS:528:DC%2BD2cXhtVCjt7%2FN (Pubitemid 39507768)
21. L Soucek J Whitfield CP Martins AJ Finch DJ Murphy NM Sodir AN Karnezis LB Swigart S Nasi GI Evan 2008 Modelling Myc inhibition as a cancer therapy Nature 455 679 683 18716624 10.1038/nature07260 1:CAS:528:DC%2BD1cXhtF2hsbnO
22. GK Gittes 2009 Developmental biology of the pancreas: a comprehensive review Dev Biol 326 4 35 19013144 10.1016/j.ydbio.2008.10.024 1:CAS:528:DC%2BD1MXhtlKgs7o%3D
23. C Bonal PL Herrera 2008 Genes controlling pancreas ontogeny Int J Dev Biol 52 823 835 18956314 10.1387/ijdb.072444cb 1:CAS:528:DC%2BD1cXhsVKju7jE
24. J Jensen 2004 Gene regulatory factors in pancreatic development Dev Dyn 229 176 200 14699589 10.1002/dvdy.10460 1:CAS:528:DC%2BD2cXht1egsLw%3D (Pubitemid 38036833)
25. LC Murtaugh 2008 The what, where, when and how of Wnt/beta-catenin signaling in pancreas development Organogenesis 4 81 86 18953422 10.4161/org.4.2.5853 (Pubitemid 351881304)
26. TC He AB Sparks C Rago H Hermeking L Zawel LT da Costa PJ Morin B Vogelstein KW Kinzler 1998 Identification of c-Myc as a target of the APC pathway Science 281 1509 1512 9727977 10.1126/science.281.5382.1509 1:CAS:528:DyaK1cXlvFGntr0%3D (Pubitemid 28425575)
27. JM Wells F Esni GP Boivin BJ Aronow W Stuart C Combs A Sklenka SD Leach AM Lowy 2007 Wnt/beta-catenin signaling is required for development of the exocrine pancreas BMC Dev Biol 7 4 17222338 10.1186/1471-213X-7-4 (Pubitemid 46201620)
28. S Papadopoulou H Edlund 2005 Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function Diabetes 54 2844 2851 16186384 10.2337/diabetes.54.10.2844 1:CAS:528:DC%2BD2MXhtV2rs77P (Pubitemid 41401078)
29. Q Zhou AC Law J Rajagopal WJ Anderson PA Gray DA Melton 2007 A multipotent progenitor domain guides pancreatic organogenesis Dev Cell 13 103 114 17609113 10.1016/j.devcel.2007.06.001 1:CAS:528:DC%2BD2sXns1yiurc%3D (Pubitemid 46972038)
30. SK Kim RJ MacDonald 2002 Signaling and transcriptional control of pancreatic organogenesis Curr Opin Genet Dev 12 540 547 12200159 10.1016/S0959-437X(02)00338-6 1:CAS:528:DC%2BD38XmsVChsbo%3D (Pubitemid 35013536)
31. PW Heiser J Lau MM Taketo PL Herrera M Hebrok 2006 Stabilization of beta-catenin impacts pancreas growth Development 133 2023 2032 16611688 10.1242/dev.02366 1:CAS:528:DC%2BD28XmtV2itb8%3D (Pubitemid 43881267)
32. A Strom C Bonal R Ashery-Padan N Hashimoto ML Campos A Trumpp T Noda Y Kido FX Real F Thorel PL Herrera 2007 Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas Development 134 2719 2725 17596282 10.1242/dev.02875 1:CAS:528:DC%2BD2sXhtVWnu7%2FN (Pubitemid 47305051)
33. C Bonal F Thorel A Ait-Lounis W Reith A Trumpp PL Herrera 2009 Pancreatic inactivation of c-Myc decreases acinar mass and transdifferentiates acinar cells into adipocytes in mice Gastroenterology 136 309 319 19022256 10.1053/j.gastro.2008.10.015 1:CAS:528:DC%2BD1MXht1Cqs7Y%3D
34. H Nakhai JT Siveke L Mendoza-Torres RM Schmid 2008 Conditional inactivation of Myc impairs development of the exocrine pancreas Development 135 3191 3196 18715949 10.1242/dev.017137 1:CAS:528:DC%2BD1cXhtlCntbrF
35. A Apelqvist H Li L Sommer P Beatus DJ Anderson T Honjo DA Hrabe U Lendahl H Edlund 1999 Notch signalling controls pancreatic cell differentiation Nature 400 877 881 10476967 10.1038/23716 1:CAS:528:DyaK1MXlslGksbw%3D Nature 400: 877-881 (Pubitemid 29406724)
36. J Jensen EE Pedersen P Galante J Hald RS Heller M Ishibashi R Kageyama F Guillemot P Serup OD Madsen 2000 Control of endodermal endocrine development by Hes-1 Nat Genet 24 36 44 10615124 10.1038/71657 1:CAS:528:DC%2BD3cXks1emsA%3D%3D (Pubitemid 30041417)
37. A Klinakis M Szabolcs K Politi H Kiaris S Artavanis-Tsakonas A Efstratiadis 2006 Myc is a Notch1 transcriptional target and a requisite for Notch1- induced mammary tumorigenesis in mice Proc Natl Acad Sci U S A 103 9262 9267 16751266 10.1073/pnas.0603371103 1:CAS:528:DC%2BD28XmsVWjt7w%3D (Pubitemid 43902566)
38. AP Weng JM Millholland Y Yashiro-Ohtani, et al. 2006 c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma Genes Dev 20 2096 2109 16847353 10.1101/gad.1450406 1:CAS:528:DC%2BD28XosVeltLc%3D (Pubitemid 44157460)
39. H Hermeking C Rago M Schuhmacher, et al. 2000 Identification of CDK4 as a target of c-MYC Proc Natl Acad Sci U S A 97 2229 2234 10688915 10.1073/pnas.050586197 1:CAS:528:DC%2BD3cXhslKhtL4%3D (Pubitemid 30134051)
40. H Yamada H Sakamoto M Taira S Nishimura Y Shimosato M Terada T Sugimura 1986 Amplifications of both c-Ki-ras with a point mutation and c- myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes Jpn J Cancer Res 77 370 375 3009377 1:CAS:528:DyaL28Xit1akt7g%3D (Pubitemid 16095449)
41. EH Mahlamaki M Barlund M Tanner L Gorunova M Hoglund R Karhu A Kallioniemi 2002 Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.Genes Chromosomes Cancer 35 353 358 1:CAS:528:DC%2BD38XptVGis70%3D (Pubitemid 35246993)
42. GH Sakorafas A Lazaris AG Tsiotou G Koullias MT Glinatsis BC Golematis 1995 Oncogenes in cancer of the pancreas Eur J Surg Oncol 21 251 253 7781791 10.1016/S0748-7983(95)91294-0 1:STN:280:DyaK2MzgtV2rtQ%3D%3D
43. N Zojer M Fiegl L Mullauer A Chott S Roka J Ackermann M Raderer H Kaufmann A Reiner H Huber J Drach 1998 Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects Br J Cancer 77 1337 1342 9579843 10.1038/bjc.1998.223 1:STN:280:DyaK1c3jvFCntA%3D%3D (Pubitemid 28140626)
44. YJ Li ZM Wei YX Meng XR Ji 2005 Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis World J Gastroenterol 11 2117 2123 15810077 1:CAS:528:DC%2BD2MXktlWrsbc%3D
45. I Hernandez-Munoz A Skoudy FX Real P Navarro 2008 Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution Pancreatology 8 462 469 18724072 10.1159/000151537
46. O Roda E Ortiz-Zapater N Martinez-Bosch R Gutierrez-Gallego M Vila-Perello C Ampurdanes HJ Gabius S Andre D Andreu FX Real P Navarro 2009 Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer Gastroenterology 136 1379 5 19171142 10.1053/j.gastro.2008.12. 039 1:CAS:528:DC%2BD1MXkslWgtrc%3D
47. AB Seymour RH Hruban M Redston C Caldas SM Powell KW Kinzler CJ Yeo SE Kern 1994 Allelotype of pancreatic adenocarcinoma Cancer Res 54 2761 2764 8168108 1:CAS:528:DyaK2cXjt1Snsbk%3D (Pubitemid 24173771)
48. G Armengol S Knuutila F Lluis G Capella R Miro MR Caballin 2000 DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma Cancer Genet Cytogenet 116 133 141 10640145 10.1016/S0165-4608(99)00118-1 1:CAS:528:DyaK1MXotVKrtLc%3D
49. C Schleger C Verbeke R Hildenbrand H Zentgraf U Bleyl 2002 c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance Mod Pathol 15 462 469 11950922 10.1038/modpathol.3880547 1:STN:280:DC%2BD383hsVGhsQ%3D%3D (Pubitemid 34326956)
50. CE Nesbit JM Tersak EV Prochownik 1999 MYC oncogenes and human neoplastic disease Oncogene 18 3004 3016 10378696 10.1038/sj.onc.1202746 1:CAS:528:DyaK1MXjs12qtLg%3D (Pubitemid 29276540)
51. AJ Wong JM Ruppert J Eggleston SR Hamilton SB Baylin B Vogelstein 1986 Gene amplification of c-myc and N-myc in small cell carcinoma of the lung Science 233 461 464 3014659 10.1126/science.3014659 1:CAS:528:DyaL28XkslKrt7s%3D (Pubitemid 16046305)
52. G Sauter P Carroll H Moch A Kallioniemi R Kerschmann P Narayan MJ Mihatsch FM Waldman 1995 c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization Am J Pathol 146 1131 1139 7747807 1:STN:280:DyaK2M3ms1KmtQ%3D%3D
53. M Buchholz A Schatz M Wagner P Michl T Linhart G Adler TM Gress V Ellenrieder 2006 Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway EMBO J 25 3714 3724 16874304 10.1038/sj.emboj.7601246 1:CAS:528:DC%2BD28XnvVGlsLk%3D (Pubitemid 44264881)
54. PG Hogan L Chen J Nardone A Rao 2003 Transcriptional regulation by calcium, calcineurin, and NFAT Genes Dev 17 2205 2232 12975316 10.1101/gad.1102703 1:CAS:528:DC%2BD3sXnsFaitbo%3D (Pubitemid 37128637)
55. JP Viola LD Carvalho BP Fonseca LK Teixeira 2005 NFAT transcription factors: from cell cycle to tumor development Braz J Med Biol Res 38 335 344 15761612 10.1590/S0100-879X2005000300003 1:CAS:528:DC%2BD2MXjsFejsrw%3D (Pubitemid 40485172)
56. A Konig T Linhart K Schlengemann, et al. 2010 NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells Gastroenterology 138 1189 1199 10.1053/j.gastro.2009.10.045
57. M Pasca di Magliano AV Biankin PW Heiser DA Cano PJ Gutierrez T Deramaudt D Segara AC Dawson JG Kench SM Henshall RL Sutherland A Dlugosz AK Rustgi M Hebrok 2007 Common activation of canonical Wnt signaling in pancreatic adenocarcinoma PLoS ONE 2 e1155 17982507 10.1371/journal.pone.0001155 (Pubitemid 351597636)
58. Q Qiao M Ramadani S Gansauge F Gansauge G Leder HG Beger 2001 Reduced membranous and ectopic cytoplasmic expression of beta-catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer Int J Cancer 95 194 197 11307154 10.1002/1097-0215(20010520)95:3<194::AID-IJC1033>3.0. CO;2-M 1:CAS:528:DC%2BD3MXjvFOmtr0%3D (Pubitemid 32477236)
59. AJ Karayiannakis KN Syrigos A Polychronidis C Simopoulos 2001 Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis Anticancer Res 21 4127 4134 11911306 1:CAS:528:DC%2BD38Xis1artbw%3D (Pubitemid 34229299)
60. YE Joo JS Rew CS Park SJ Kim 2002 Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma Pancreatology 2 129 137 12123093 10.1159/000055903 1:CAS:528:DC%2BD38XjtlSjtL4%3D (Pubitemid 34639088)
61. AM Lowy C Fenoglio-Preiser OJ Kim J Kordich A Gomez J Knight L James J Groden 2003 Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma Ann Surg Oncol 10 284 290 12679314 10.1245/ASO.2003.05.003 (Pubitemid 40486962)
62. YJ Li XR Ji 2003 Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer World J Gastroenterol 9 368 372 12532469 1:CAS:528:DC%2BD3sXhsFymsrk%3D
63. S Jesse A Koenig V Ellenrieder A Menke 2010 Lef-1 isoforms regulate different target genes and reduce cellular adhesion Int J Cancer 126 1109 1120 19653274 1:CAS:528:DC%2BC3cXjsFCl
64. L Zhao PK Vogt 2008 Class I PI3K in oncogenic cellular transformation Oncogene 27 5486 5496 18794883 10.1038/onc.2008.244 1:CAS:528: DC%2BD1cXhtFWiur%2FP
65. MG Schlieman BN Fahy R Ramsamooj L Beckett RJ Bold 2003 Incidence, mechanism and prognostic value of activated AKT in pancreas cancer Br J Cancer 89 2110 2115 14647146 10.1038/sj.bjc.6601396 1:STN:280:DC%2BD3srmsFOjsg%3D%3D (Pubitemid 38030911)
66. NA Pham J Schwock V Iakovlev G Pond DW Hedley MS Tsao 2008 Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis BMC Cancer 8 43 18254976 10.1186/1471-2407-8-43 (Pubitemid 351454858)
67. T Asano Y Yao J Zhu D Li JL Abbruzzese SA Reddy 2004 The PI 3- kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells Oncogene 23 8571 8580 15467756 10.1038/sj.onc.1207902 1:CAS:528:DC%2BD2cXpsF2msrk%3D (Pubitemid 39576463)
68. M Reichert D Saur R Hamacher RM Schmid G Schneider 2007 Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells Cancer Res 67 4149 4156 17483325 10.1158/0008-5472.CAN-06-4484 1:CAS:528:DC%2BD2sXltVyrsrg%3D (Pubitemid 46815060)
69. C Schild M Wirth RM Schmid D Saur G Schneider 2009 PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells Mol Carcinog 48 12 1149 1158 19603422 10.1002/mc.20569 1:CAS:528:DC%2BD1MXhsVyls7vL
70. JA Silverman ET Kuhlmann J Zurlo JD Yager DS Longnecker 1990 Expression of c-myc, c-raf-1, and c-Ki-ras in azaserine-induced pancreatic carcinomas and growing pancreas in rats Mol Carcinog 3 379 386 2278633 10.1002/mc.2940030610 1:CAS:528:DyaK3MXitVCksL8%3D
71. EP Sandgren CJ Quaife AG Paulovich RD Palmiter RL Brinster 1991 Pancreatic tumor pathogenesis reflects the causative genetic lesion Proc Natl Acad Sci U S A 88 93 97 1986386 10.1073/pnas.88.1.93 1:CAS:528: DyaK3MXnvFCnuw%3D%3D (Pubitemid 21914433)
72. BK Schaeffer PG Terhune DS Longnecker 1994 Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations Am J Pathol 145 696 701 8080049 1:CAS:528: DyaK2cXmslOksr4%3D
73. DJ Liao Y Wang J Wu NV Adsay D Grignon F Khanani FH Sarkar 2006 Characterization of pancreatic lesions from MT-TGF alpha, Ela-myc and MT-TGF alpha/Ela-myc single and double transgenic mice J Carcinog 5 19 16822304 10.1186/1477-3163-5-19 (Pubitemid 44390028)
74. JD Liao NV Adsay F Khannani D Grignon A Thakur FH Sarkar 2007 Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer Histol Histopathol 22 661 676 17357096 1:STN:280:DC%2BD2s7ls1Ohsw%3D%3D (Pubitemid 46647278)
75. S Aguilar JM Corominas N Malats M Dufresne FX Real P Navarro 2003 Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression Am J Pathol 165 1129 1139 10.1016/S0002-9440(10)63374-3
76. BC Lewis DS Klimstra HE Varmus 2003 The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer Genes Dev 17 3127 3138 14681205 10.1101/gad.1140403 1:CAS:528:DC%2BD2cXhs1Sgsw%3D%3D (Pubitemid 38040775)
77. S Pelengaris M Khan GI Evan 2002 Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression Cell 109 321 334 12015982 10.1016/S0092-8674(02)00738-9 1:CAS:528:DC%2BD38XjvV2lsLk%3D (Pubitemid 34606875)
78. DJ Wong H Liu TW Ridky D Cassarino E Segal HY Chang 2008 Module map of stem cell genes guides creation of epithelial cancer stem cells Cell Stem Cell 2 333 344 18397753 10.1016/j.stem.2008.02.009 1:CAS:528:DC%2BD1cXltVOnsLo%3D (Pubitemid 351455242)